Abstract
Renal osteodystrophy is a common complication of end-stage renal disease (ESRD) patients. Rarely, it can be associated with uremic leontiasis ossea (ULO) that is characterized by progressive enlargement of the facial bones and is thought to be secondary to uncontrolled secondary hyperparathyroidism (sHPTH) in the setting of ESRD. Few case reports have been described in the literature with our case appearing to be the most severe. Due to the rarity of this disease, there is no current standard of treatment.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
